Sandset PM - Search Results

1

Genotype of proband and thrombophilia screening.

Sandset PM. Sandset PM. Blood. 2013 Oct 10;122(15):2528-9. doi: 10.1182/blood-2013-08-519801. Blood. 2013. PMID: 24113791 Free article. No abstract available.

2

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Dahm A, et al. Among authors: sandset pm. Blood. 2003 Jun 1;101(11):4387-92. doi: 10.1182/blood-2002-10-3188. Epub 2003 Jan 30. Blood. 2003. PMID: 12560220 Free article.

3

Hormone therapy and raloxifene reduce the coagulation inhibitor potential.

Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM. Andresen MS, et al. Among authors: sandset pm. Blood Coagul Fibrinolysis. 2007 Jul;18(5):455-60. doi: 10.1097/MBC.0b013e32813a2de7. Blood Coagul Fibrinolysis. 2007. PMID: 17581320 Clinical Trial.

4

The association of inherited thrombophilia and intrauterine fetal death: a case-control study.

Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM. Helgadottir LB, et al. Among authors: sandset pm. Blood Coagul Fibrinolysis. 2011 Dec;22(8):651-6. doi: 10.1097/MBC.0b013e32834a614c. Blood Coagul Fibrinolysis. 2011. PMID: 22198364

5

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.

de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Miñano A, de la Morena-Barrio B, Bravo-Pérez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Trégouët DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J. de la Morena-Barrio ME, et al. Among authors: sandset pm. Blood. 2022 Jul 14;140(2):140-151. doi: 10.1182/blood.2021014708. Blood. 2022. PMID: 35486842 Free PMC article.

6

Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients.

Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U. Lindahl AK, et al. Among authors: sandset pm. Blood Coagul Fibrinolysis. 1991 Dec;2(6):713-21. doi: 10.1097/00001721-199112000-00004. Blood Coagul Fibrinolysis. 1991. PMID: 1799658

7

Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins.

Bendz B, Andersen TO, Sandset PM. Bendz B, et al. Among authors: sandset pm. Blood Coagul Fibrinolysis. 2000 Jun;11(4):343-8. doi: 10.1097/00001721-200006000-00005. Blood Coagul Fibrinolysis. 2000. PMID: 10847421

8

Low molecular weight heparin prevents activation of coagulation in a hypobaric environment.

Bendz B, Sevre K, Andersen TO, Sandset PM. Bendz B, et al. Among authors: sandset pm. Blood Coagul Fibrinolysis. 2001 Jul;12(5):371-4. doi: 10.1097/00001721-200107000-00006. Blood Coagul Fibrinolysis. 2001. PMID: 11505080 Clinical Trial.

9

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.

Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM. Opstad TB, et al. Among authors: sandset pm. Blood Coagul Fibrinolysis. 2010 Sep;21(6):516-21. doi: 10.1097/MBC.0b013e32833a06cd. Blood Coagul Fibrinolysis. 2010. PMID: 20453636

10

Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms.

Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM. Jacobsen AF, et al. Among authors: sandset pm. J Thromb Haemost. 2010 Nov;8(11):2443-9. doi: 10.1111/j.1538-7836.2010.04038.x. J Thromb Haemost. 2010. PMID: 20735725 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page